The cannabis private equity firm Tress Capital said Monday that it's making a strategic investment in Israel-Cannabis, or iCAN.
Tress, which has mostly made cannabis investments in North America, said the two companies are working on joint strategic initiatives with the aim of creating an "unmatched global canvas" of cannabis industry coverage and capabilities.
The Israel-based cannabis incubator "has pushed into multiple continents outside of our North American base, and working together — as this deal further enables — strengthens each company’s global market positioning," Tress Capital partner Jonathan Eisenberg told Benzinga.
The amount of Tress Capital's investment was not disclosed.
CannaTech, an international cannabis summit, powers iCAN.
Tress was the first global sponsor at CannaTech Tel Aviv six years ago, and the two companies have partnered every year since then, iCAN CEO Saul Kaye said in a statement.
"Tress' robust portfolio of cannabis technology companies in North America, together with iCAN's strong IP and Israel-focused portfolio, will create synergies and drive expansion for our companies."
Related Links:
Exclusive: Accela, NCS Analytics Partner On 'All-In-One' Cannabis Regulatory System
Willow Industries Launches First Non-Extraction Cannabis Remediation Facility In US
Photo by Javier Hasse.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.